Pro-Pointer, Inc. (PINKSHEETS: PPII) announced today that they have entered into a share exchange agreement with Coenzyme-A Technologies, Inc., a privately held innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the effects of aging. Under the terms of the share exchange agreement, Pro-Pointer will issue additional common stock equaling approximately 78% ownership of Pro-Pointer (including subsequent share issuances) in exchange for 100% of the issued and outstanding shares of Coenzyme-A Technologies, Inc. Subsequent to the closing of the share exchange agreement new directors and officers of the Company will be appointed.

ABOUT COENZYME-A TECHNOLOGIES, INC.

Coenzyme-A Tech. Inc. is a science-based company primarily engaged in the development of nutraceutical supplements and uniquely efficacious and patentable skin and hair care products to be available without prescription. These products are designed to make skin and hair look and feel younger on a sustained basis by attacking the cellular causes of skin aging and decreased hair density. Company website -- www.coenzyme-a.com

FORWARD-LOOKING STATEMENTS

The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Investor Relations InvestSource Inc. 714-847-2460 ext 801 Email Contact

Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Coenzyme A (CE) Charts.
Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Coenzyme A (CE) Charts.